Pastedio, Roxan .
HRN: 20-17-62 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2025
CEFUROXIME 500MG (TAB)
05/17/2025
05/23/2025
PO
500mg
BID
SP PLTCS
Waiting Final Action